Bio View

Bio View Gross Margin

The Gross Margin of Bio View (BIOV.TA) as of Oct 18, 2026 is 43.89 %. In the previous year, Gross Margin was 60.65 % — a change of -27.63% (lower).

Gross Margin

43.89 %

YoY

-27.63%

Last updated:

Gross Margin of Bio View is 2025 43.89 % . Gross Margin of Bio View was 2024 60.65 % . It decreases by -27.63% lower compared to the previous year.

For Bio View, the gross margin of 43.9% is down versus 57.6% a few years ago.

The Bio View Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
58.39 ILS
Jan 1, 2019
56.63 ILS
Jan 1, 2020
60.80 ILS
Jan 1, 2021
57.63 ILS
Jan 1, 2022
57.20 ILS
Jan 1, 2023
61.48 ILS
Jan 1, 2024
60.65 ILS
Jan 1, 2025
43.89 ILS
The Bio View Gross Margin history
YEARGross MarginYoY
43.89 %-27.63%
60.65 %-1.35%
61.48 %+7.49%
57.20 %-0.76%
57.63 %-5.21%
60.80 %+7.37%
56.63 %-3.01%
58.39 %-2.22%
59.71 %-6.13%
63.61 %+2.27%
62.20 %-3.73%
64.61 %+9,958.71%
0.64 %-2.49%
0.66 %-1.47%
0.67 %+9.31%
0.61 %+2.95%
0.59 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio View Stock analysis

What does Bio View do? Bio View Ltd, based in Rehovot, Israel, operates in the Health Care sector, specializing in the research, development, marketing, and sales of advanced imaging systems. The company manufactures and services the Duet workstation, an automated cell diagnostic system used in cytology, hematology, and pathology laboratories for detecting and analyzing abnormal cells. It also offers the ALLEGRO and ACCORD workstations for specialized applications in cancer diagnosis, minimal-residual disease monitoring, and FISH-based analyses in cytogenetics and oncology. Bio View is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio View stock

Gross Margin of Bio View is 43.89 % in 2025.

Gross Margin of Bio View changed from 60.65 % to 43.89 %, representing a -27.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Bio View since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Bio View with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Bio View

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Bio View